All News about Lexaria Bioscience Corp
Lexaria Oral Nicotine Study NIC-A21-1 Delivers Outstanding Results
October 05, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria's DehydraTECH-CBD Lowers Blood Pressure
July 29, 2021
Via AccessWire
Topics
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.